Global high impact executives
There are more executive interims working in life sciences organisations than ever before. With global reach and diverse skill sets that can drive your business from pre-clinical development through commercialisation, change management, HR to C-Suite – we work with the most talented individuals to provide proven ‘high impact’ executives who successfully deliver short to mid-term objectives.
- Are a mobile strategic deployment, flexible and targeted at specific goals.
- Provide a growing company with the expertise it needs without having to bear the long-term retention costs of a permanent hire.
- Are a valuable resource whilst searching for full time staff: they provide instant capability and help in shaping the role.
- Bridge unexpected gaps caused by illness or loss of key people.
- Advise and implement projects where businesses are moving into new therapeutic areas or geographies.
Executive interims
How we help
We do the due diligence that means we understand the skills, availability and motivation of our executive interims so that we can advise you on the ‘best fit’ candidate for your solution and represent them authentically to you. You don’t have to worry about the paperwork and the negotiation either, we take care of that, making the process hassle free.
The RSA Group Executive Interim Solutions - Case Studies
“As the interim HRD at Immunocore I appointed RSA to run Executive Searches for two key SVP/VP roles in Autoimmune Translation and in Haematology. Their care and attention in taking and defining the brief, and the subsequent quality of their research, finding a range of credible and appointable candidates from around Europe and the States was exemplary.
I’ve always enjoyed working with RSA, for their excellent communications, their professionalism, their deep knowledge of the life sciences market and their aftercare of candidates that are unsuccessful.”
Ted Smith , Formerly VP HR at GSK, Vernalis, MRC and Wellcome Trust
Latest News
30 Mar 2021
The RSA Group completes search for Clinigen Group – Sharon Curran appointed as Non-Executive Director
29 Mar 2021
Placement | The RSA Group completes successful search for Fusion Antibodies – Dr Richard Jones appointed as Chief Executive Officer
08 Mar 2021
Clara Schäfer joins The RSA Group as Executive Assistant
